研究者総覧 - 田代　渉

タシロ　ショウ
田代　渉

所属大分大学医学部附属病院中診特診・薬剤部

職種助教

論文
論文	Ampicillin sulbactam impacts serum potassium level comparable to piperacillin tazobactam. Scientific reports 15 (1),35517-35517頁 2025/10/10
論文	セフトリアキソンによる抗菌薬関連脳症への血液透析および血漿交換の有効性を検討した急速進行性糸球体腎炎による急性腎障害の1例日本透析医学会雑誌 57 (2),93-98頁 2024/01
論文	Oral teicoplanin administration suppresses recurrence of Clostridioides difficile infection: Proof of concept. Anaerobe 84,102789-102789頁 2023/12
論文	Antimicrobial Efficacy Evaluations of Metronidazole against Clostridioides difficile Infection using Fecal Pharmacokinetic and Pharmacodynamic Analyses. Pharmaceutical research 40 (7),1799-1806頁 2023/07
論文	Optimal therapeutic recommendation for Clostridioides difficile infection in pediatric and adolescent populations: a systematic review and meta-analysis. European journal of pediatrics 182 (6),2673-2681頁 2023/06
論文	Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 29 (5),616-622頁 2023/05
論文	Differences in Pharmacokinetic/Pharmacodynamic Parameters of Tedizolid Against VRE and MRSA. Pharmaceutical research 40 (1),187-196頁 2023/01
論文	Oral fidaxomicin versus vancomycin for the treatment of Clostridioides difficile infection: A systematic review and meta-analysis of randomized controlled trials. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 28 (11),1536-1545頁 2022/11
論文	Efficacy of surgical skin preparation with chlorhexidine in alcohol according to the concentration required to prevent surgical site infection: meta-analysis. BJS open 6 (5) 2022/09/02
論文	Target Therapeutic Ranges of Anti-MRSA Drugs, Linezolid, Tedizolid and Daptomycin, and the Necessity of TDM. Biological & pharmaceutical bulletin 45 (7),824-833頁 2022/07
論文	Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis. Pharmaceutics 14 (4) 2022/03/27
論文	Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments. Pharmaceutical research 38 (11),1839-1846頁 2021/11
論文	低体重な血液透析患者において非常に高いセフトリアキソン血中濃度を認めた抗菌薬関連脳症と考えられる1例日本化学療法学会雑誌 69 (6),433-439頁 2021/11
論文	The optimal trough-guided monitoring of vancomycin in children: Systematic review and meta-analyses. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 27 (5),781-785頁 2021/05
論文	The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing. BMC infectious diseases 21 (1),153-153頁 2021/02/06
論文	Pharmacokinetics/Pharmacodynamics Evaluation of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli In Vitro and In Vivo in a Murine Thigh Infection Model. Pharmaceutical research 38 (1),27-35頁 2021/01
論文	Azoles versus conventional amphotericin B for the treatment of candidemia: A meta-analysis of randomized controlled trials. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 26 (11),1232-1236頁 2020/11
論文	Echinocandins versus non-echinocandins for the treatment of invasive candidiasis: A meta-analysis of randomized controlled trials. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 26 (11),1164-1176頁 2020/11
論文	Factorial analysis of Clostridioides difficile colitis and pseudomembranous colitis using JADER BPB Reports 3 (1),1-6頁 2020/11
論文	Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 24 (11),907-914頁 2018/11